Benign neoplasm: Ciliary body

CD2_BENIGN_CILIARY

stomach neoplasm: A benign or malignant neoplasm involving the stomach.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D31.4& Cause of death: ICD-10 — D31.4& 2 out of 7 registries used, show all original rules.	105
4. Check minimum number of events None	105
5. Include endpoints None	105
6. Filter based on genotype QC (FinnGen only)	104

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D31
Name in latin: Neoplasma benignum corporis ciliaris

NAME	CD2_BENIGN_CILIARY
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D314
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D314
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Ciliary body based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	562	332	227
Only index persons	535	325	210
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	61.29	61.05	61.90
Only index persons	61.53	61.28	61.92

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	104	57	47
Unadjusted period prevalence (%)	0.02	0.02	0.02
Median age at first event (years)	64.26	60.18	69.21

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
105: Matched controls
1050

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D31.4

ICD-10 Finland

Benign neoplasm: Ciliary body

+∞

151.4

105

XCD10

NOMESCO Finland

Electrophysiological examination of eye

58.1

78.3

CH2S4

NOMESCO Finland

Photography of iris

+∞

27.3

XCK10

NOMESCO Finland

Photography of fundus of eye

9.4

26.4

D31.3

ICD-10 Finland

Benign neoplasm: Choroid

56.3

25.2

Z3229

NOMESCO Finland

Other healthcare associate professional

7.5

16.9

Z01.0

ICD-10 Finland

Examination of eyes and vision

5.1

14.4

126

CH3S4

NOMESCO Finland

Photography of iridocorneal angle

+∞

11.7

CD2S4

NOMESCO Finland

Photography of eye

44.6

10.2

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

33.5

9.6

H21.3

ICD-10 Finland

Cyst of iris, ciliary body and anterior chamber

+∞

9.5

C69.40

ICD-10 Finland

Malignant tumor of ciliary body without histology

+∞

8.4

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

4.0

6.7

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

74.2

6.5

H21.8

ICD-10 Finland

Other specified disorders of iris and ciliary body

74.2

6.5

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

6.1

6.5

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3045142) Bone marrow Pathology biopsy report

5.19

2.09

1.0

1.3

—

(1761868) Lipid panel - Serum or Plasma

309

1.73

1.95

3.1

—

(40768797) Stomach Pathology biopsy report

147

1.82

1.66

1.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

279

1.63

1.55

3.4

3.2

801.24

964.64

ng/l

0.33

237

(3022217) INR in Platelet poor plasma by Coagulation assay

449

1.59

1.52

20.6

12.5

1.20

1.22

inr

0.06

133

(3020564) Creatinine [Moles/volume] in Serum or Plasma

100

926

2.68

1.48

18.7

18.0

79.40

79.58

umol/l

0.03

100

926

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

3.23

1.45

1.6

—

(3002256) Pathology report gross observation

100

1.84

1.33

1.4

1.2

—

(40761511) CBC panel - Blood by Automated count

907

2.21

1.33

14.1

14.2

—

(3023520) Reticulocytes [#/volume] in Blood

1.89

1.24

1.7

2.9

74.74

74.17

e9/l

—

(3044889) 12 lead EKG panel

646

1.56

1.23

4.5

4.2

—

(21494755) Public health laboratory ask at order entry panel

1.92

1.21

1.2

1.5

—

(3021589) Normoblasts [#/volume] in Blood

379

1.49

1.18

9.9

10.4

0.00

e9/l

0.71

320

(40760892) CBC W Ordered Manual Differential panel - Blood

408

1.49

1.18

6.9

6.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

188

1.59

1.17

2.1

1.8

500.14

454.18

pmol/l

0.41

153

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

875

1.90

1.11

15.4

15.2

20.67

22.88

mg/l

0.26

695

(42529406) Shigella sp [Presence] in Stool by Culture

2.27

1.10

1.0

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2.27

1.10

1.0

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

2.45

1.10

1.0

1.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

375

1.46

1.08

2.2

82.60

78.39

nmol/l

0.42

327

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

646

1.49

1.05

4.4

4.1

14.89

14.80

pmol/l

0.13

572

(3030467) Casts [#/volume] in Urine by Automated count

256

1.49

1.04

4.1

2.9

0.41

0.39

e6/l

0.03

190

(3019550) Sodium [Moles/volume] in Serum or Plasma

908

1.90

1.03

18.6

17.8

139.93

139.72

mmol/l

0.39

888

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

0.00

0.99

0.0

1.3

—

3.25

—

(3037121) Protein [Mass/volume] in Urine

0.00

0.99

0.0

3.5

—

0.18

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

0.00

0.99

0.0

1.3

—

2.36

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.98

0.0

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

491

1.40

0.92

2.8

—

(3002582) Erythrocytes [#/volume] in Urine

280

1.43

0.92

3.9

3.2

15.31

262.54

e6/l

0.55

215

(36304419) Bacteria [Presence] in Urine

253

1.44

0.91

4.0

2.9

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

839

1.63

0.91

18.0

14.4

76.13

78.05

ml/min/173m2

0.43

685

(3008898) HLA-B27 [Presence]

2.13

0.91

1.0

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

228

1.44

0.86

1.5

1.7

1.00

1.34

mmol/l

3.07

190

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

798

1.53

0.84

5.1

4.9

1.86

1.92

mu/l

0.19

715

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.93

0.83

1.0

1.2

—

(1002224) Polysomnography panel

1.93

0.83

1.0

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

0.00

0.80

0.0

5.2

—

30.14

—

(40768804) Tissue Pathology biopsy report

372

1.37

0.80

2.0

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

353

1.37

0.79

2.9

2.6

111.89

135.02

ug/l

0.37

319

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

107

0.53

0.77

1.2

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.90

0.75

1.4

1.9

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

415

1.34

0.73

3.8

6.3

1.21

mmol/l

0.22

372

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

861

1.55

0.72

4.8

4.7

1.44

1.48

mmol/l

0.40

781

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

129

0.59

0.69

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

886

1.58

0.68

5.4

5.2

2.70

2.71

mmol/l

0.06

809

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.55

0.68

2.6

3.5

—

(3002030) Lymphocytes/100 leukocytes in Blood

409

1.32

0.67

4.7

5.9

25.14

27.23

0.46

379

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.63

0.66

1.0

1.3

—

(3042936) Bacteria identified in Isolate by Culture

137

0.62

0.66

1.4

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

345

0.74

0.63

3.2

3.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

867

1.49

0.62

4.9

4.7

4.56

4.65

mmol/l

0.34

800

(3018418) pH of Serum or Plasma

288

1.32

0.62

3.9

4.2

7.41

7.40

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

150

1.41

0.62

3.7

2.7

1.30

2.24

e6/l

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

0.61

0.0

1.5

—

5.63

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.61

0.0

1.2

—

(40761536) Microorganisms panel - Urine sediment

1.54

0.60

4.5

3.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.55

0.60

1.9

1.8

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.59

0.0

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

837

1.42

0.57

6.2

39.49

40.36

mmol/mol

0.57

783

(3026008) Bacteria identified in Urine by Culture

266

0.74

0.56

3.1

2.7

—

(3000494) Fungus identified in Specimen by Culture

109

0.62

0.52

1.6

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

378

0.78

0.51

3.7

4.0

31.82

37.47

ng/l

0.11

272

(3013707) Erythrocyte sedimentation rate by Westergren method

653

1.27

0.49

4.1

4.2

8.50

12.17

mm/h

1.67

594

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

452

1.25

0.49

4.9

7.2

1.21

mmol/l

0.02

377

(3018095) Leukocytes [#/volume] in Urine

316

1.26

0.49

4.8

3.7

18.11

40.96

e6/l

1.31

231

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1.46

0.47

2.4

4.0

4.31

4.55

pmol/l

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

308

1.26

0.46

4.3

4.8

1.50

2.01

ug/l

1.12

271

(3017143) Hepatitis C virus Ab [Presence] in Serum

0.62

0.44

1.2

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

106

1.37

0.41

2.0

1.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

106

1.37

0.41

2.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.41

0.0

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

0.00

0.41

0.0

1.3

—

185.97

—

(40768800) Prostate Pathology biopsy report

0.00

0.41

0.0

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.36

0.41

1.6

2.1

—

(3025941) Bacteria identified in Stool by Culture

1.36

0.41

1.0

1.3

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

0.40

0.0

3.7

—

8.53

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

0.40

0.0

3.7

—

1.50

—

(3022145) Colonoscopy Study observation

1.37

0.39

1.0

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.39

0.0

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

418

0.82

0.38

2.1

2.5

—

(3027801) Oxygen [Partial pressure] in Arterial blood

121

0.72

0.38

2.8

7.8

12.46

11.85

kpa

—

115

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

121

0.72

0.38

2.8

7.8

5.42

5.25

kpa

—

115

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

145

1.29

0.37

1.1

1.3

113.50

33.04

iu/ml

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.38

0.35

1.4

1.6

—

(3013115) Eosinophils [#/volume] in Blood

444

1.19

0.35

6.4

5.9

0.19

e9/l

0.06

395

(3029937) Albumin [Presence] in Urine by Test strip

239

0.80

0.34

3.4

4.1

0.00

estimate

-0.00

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

205

0.80

0.31

1.9

2.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

106

0.73

0.31

4.6

8.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.29

0.30

2.1

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

177

1.23

0.30

2.6

1.7

1145.92

1300.14

nmol/l

0.26

129

(46235355) HIV 1 and 2 tests - Meaningful Use set

127

0.77

0.27

1.2

1.7

—

(3000492) Spirometry study

1.22

0.26

1.2

1.5

—

(3006315) Basophils [#/volume] in Blood

426

1.14

0.23

5.3

5.8

0.04

e9/l

0.55

375

(3001604) Monocytes [#/volume] in Blood

426

1.14

0.23

5.3

5.8

0.62

0.58

e9/l

0.26

375

(3013650) Neutrophils [#/volume] in Blood by Automated count

516

1.14

0.22

10.8

9.8

3.97

4.03

e9/l

0.10

450

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

329

1.14

0.21

3.6

3.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

3.0

—

148.06

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.21

0.0

4.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.21

0.0

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

4.0

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

0.21

0.0

4.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.21

0.0

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.21

0.0

4.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.21

0.0

1.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.21

0.0

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.21

0.0

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.21

0.0

1.4

—

(3038026) Centromere Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3045424) Erythrocytes [Presence] in Urine

0.00

0.21

0.0

1.5

—

(3003181) Sodium [Moles/volume] in Urine

0.00

0.21

0.0

1.5

—

64.40

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.21

0.0

1.4

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.21

0.0

1.4

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.21

0.0

1.4

—

(40768441) Liver Pathology biopsy report

0.00

0.21

0.0

1.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

271.50

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.21

0.0

3.6

—

104.75

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

503.33

—

(3011288) Drugs identified in Urine by Screen method

0.00

0.21

0.0

1.3

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

13.76

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

0.00

0.21

0.0

1.5

—

1.83

—

(40768795) Lymph node Pathology biopsy report

0.00

0.21

0.0

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.17

—

(3023410) Appearance of Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.0

—

36.00

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.21

0.0

3.6

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.21

0.0

3.6

—

3.97

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

0.00

0.21

0.0

2.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

844

1.18

0.20

4.4

4.2

1.15

1.29

mmol/l

1.56

760

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.20

0.0

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.00

0.20

0.0

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.21

0.20

1.7

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

321

1.14

0.20

2.9

3.7

2.33

2.35

mmol/l

0.57

285

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

856

1.17

0.18

4.9

4.8

5.89

6.00

mmol/l

0.41

783

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

158

1.17

0.17

4.0

2.6

1.00

0.94

e6/l

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.17

0.17

1.1

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

0.79

0.16

3.8

2.1

10.22

9.73

g/l

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1.11

0.15

2.4

7.5

9.59

9.45

mmol/l

—

(3019198) Lymphocytes [#/volume] in Blood

437

1.09

0.13

5.3

5.8

2.61

1.90

e9/l

0.30

396

(40758558) Short blood count panel - Blood

222

1.11

0.11

10.4

8.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

144

1.13

0.11

2.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

176

0.89

0.10

1.2

1.6

2.38

3.03

g/l

—

106

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.14

0.10

2.8

2.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.14

0.10

1.8

1.2

—

(3000330) Specific gravity of Urine by Test strip

1.12

0.10

2.0

3.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

194

1.10

0.10

1.6

1.7

1.66

1.44

mg/l

0.10

168

(3028026) IgM [Mass/volume] in Serum or Plasma

0.78

0.08

1.4

1.7

0.99

1.12

g/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.05

0.08

1.7

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

194

0.91

0.08

2.1

4.0

—

(3044640) Blood type and Crossmatch panel - Blood

285

0.93

0.07

2.0

2.3

—

(3019225) pH of Specimen

1.03

0.07

1.5

4.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.03

0.07

2.1

1.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

355

1.07

0.07

2.2

2.0

96.41

95.91

pmol/l

0.01

176

(4035726) Immunohistochemistry procedure

1.12

0.06

1.4

1.3

—

(3012516) Albumin [Mass/volume] in Urine

272

0.94

0.05

3.0

3.3

19.77

303.61

mg/l

0.59

165

(3020682) Albumin/Creatinine [Ratio] in Urine

292

0.94

0.05

3.3

3.9

2.80

7.50

mg/mmol

1.22

163

(3021601) Nitrite [Presence] in Urine by Test strip

432

0.95

0.04

4.1

4.8

0.00

estimate

-0.00

(3031040) Bacteria [#/volume] in Urine by Automated count

571

0.96

0.04

4.5

4.2

—

362.91

—

(3037467) Urinalysis macro (dipstick) panel - Urine

600

1.04

0.03

3.7

4.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

252

1.04

0.02

3.2

3.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

183

1.05

0.01

2.8

2.9

0.70

0.74

ug/l

—

127

(3037522) Nuclear Ab [Titer] in Serum

112

0.98

0.00

1.1

1.4

—

552.59

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

117

1.03

0.00

2.6

7.8

106.25

103.91

mmol/l

1.72

117

(3023368) Bacteria identified in Blood by Culture

247

1.02

0.00

5.3

4.5

—

(3003694) ABO and Rh group [Type] in Blood

225

1.03

0.00

1.3

1.4

—

(3013512) EKG study

266

1.02

0.00

4.0

4.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

284

0.98

0.00

2.4

2.5

73.64

72.94

u/l

0.01

261

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

246

1.02

0.00

3.2

4.3

27.17

22.55

—

117

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

116

1.04

0.00

1.3

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

101

0.99

0.00

1.2

1.8

—

(3009261) Glucose [Presence] in Urine by Test strip

436

1.02

0.00

2.9

3.7

0.00

estimate

-0.00

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.02

0.00

4.3

5.6

25.18

25.36

mmol/l

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

259.88

—

(3016018) Differential panel - Cerebral spinal fluid

0.00

0.0

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

0.0

15.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

1.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.9

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

0.0

1.5

—

(3017569) Oxygen content in Arterial blood

0.00

0.0

9.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

-0.00

0.0

2.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

17.3

—

693.00

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

0.89

-0.00

1.0

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.6

—

(36660697) Celiac disease serology panel - Serum

0.98

-0.00

1.2

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

0.00

-0.00

0.0

1.6

—

(3005570) Glucose [Moles/volume] in Urine

0.00

-0.00

0.0

3.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

233.00

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.80

—

(3044927) Protein electrophoresis panel - Urine

0.00

-0.00

0.0

1.2

—

(40765096) Chromosome analysis panel by Banding

0.00

-0.00

0.0

1.0

—

(3035350) Ketones [Presence] in Urine by Test strip

430

1.00

-0.00

2.9

3.7

0.00

estimate

-0.00

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

3.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3035880) pH of Pleural fluid

0.00

-0.00

0.0

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.8

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.96

-0.00

2.0

1.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

-0.00

0.0

1.6

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

29.60

—

(3010375) cycloSPORINE [Mass/volume] in Blood

0.00

-0.00

0.0

45.0

—

107.00

—

(3047189) Immunofixation for 24 hour Urine

0.00

-0.00

0.0

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

-0.00

0.0

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

-0.00

0.0

1.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.00

-0.00

0.0

2.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.3

—

75.00

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

-0.00

0.0

1.0

—

(3020491) Glucose [Moles/volume] in Blood

0.00

-0.00

0.0

2.1

—

7.06

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

-0.00

0.0

1.0

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.00

-0.00

0.0

1.4

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

-0.00

0.0

1.5

—

(3022621) pH of Urine by Test strip

0.93

-0.00

2.3

2.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

0.00

-0.00

0.0

2.1

—

11.86

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

68.40

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

(3004451) EKG impression Narrative

0.00

-0.00

0.0

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

-0.00

0.0

1.6

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

21.7

—

1123.33

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

0.89

-0.00

1.3

1.9

1.18

1.51

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

-0.00

0.0

1.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

2.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

-0.00

0.0

5.2

—

58.20

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

-0.00

0.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

-0.00

0.0

1.5

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

12.68

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

-0.00

0.0

2.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_CILIARY and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_CILIARY.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_CILIARY – Benign neoplasm: Ciliary body

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Ciliary body

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints